₹405
Description:
Alogliptin is prescribed to reduce high blood sugar level in patients with type 2 diabetes along with diet control and exercise.It should not be used in treating diabetic ketoacidosis or type 1 diabetes.
Consume Type:
PO - The initial dose is based on patient's condition. Maximum recommended dose is 25/2000mg.
Best before: 23-12-2025
SideEffects:
Upper respiratory tract infection, heart attack, throat inflammation, diarrhea, high blood pressure, headache, back pain and urinary tract infection.
Manufacturer:
Novartis AG
Disclaimer:
Use as directed by your doctor.